The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase 1 study to evaluate the safety and tolerability of MEDI4736 (durvalumab, DUR) + tremelimumab (TRE) in patients with advanced solid tumors.
 
Margaret K. Callahan
Employment - Bristol-Myers Squibb (I); Celgene (I); Kleo Pharmaceuticals (I)
Consulting or Advisory Role - AstraZeneca; Moderna Therapeutics
Research Funding - Bristol-Myers Squibb (Inst)
Other Relationship - Clinical Care Options; Potomac Center for Medical Education
 
Kunle Odunsi
Research Funding - ITeos Therapeutics (Inst)
 
Mario Sznol
Stock and Other Ownership Interests - Adaptive Biotechnologies; Amphivena; Intensity Therapeutics
Consulting or Advisory Role - Adaptimmune; Agonox; Alexion Pharmaceuticals; Amgen; Anaeropharma; Astellas Pharma; AstraZeneca/MedImmune; Biodesix; Bristol-Myers Squibb; Genentech/Roche; Immune Design; Immune Design; Inovio Pharmaceuticals; Janssen Oncology; Kyowa Hakko Kirin; Lilly; Lion Biotechnologies; Lycera; Merck Sharp & Dohme; Merus; Modulate Pharma; Nektar; Novartis; Omniox; pfizer; Prometheus; Seagen; Symphony Evolution; Theravance; Vaccinex
Other Relationship - AcademicCME; Clinical Care Options; Dava Oncology; Haymarket Media; Imedex; Physicans' Education Resource; Prime Oncology; Research to Practice; TRM Oncology; Vindico
 
John J. Nemunaitis
Employment - Gradalis
Leadership - Gradalis
Stock and Other Ownership Interests - Gradalis
Honoraria - Amgen; AstraZeneca
Consulting or Advisory Role - Amgen; AstraZeneca
Speakers' Bureau - Amgen; AstraZeneca
Patents, Royalties, Other Intellectual Property - Gradalis
Travel, Accommodations, Expenses - Amgen; AstraZeneca; Baxalta; Takeda
 
Patrick Alexander Ott
Consulting or Advisory Role - Alexion Pharmaceuticals; Amgen; Bristol-Myers Squibb; Celldex; CytomX Therapeutics; Genentech; Neon Therapeutics
Research Funding - ARMO BioSciences (Inst); AstraZeneca/MedImmune (Inst); Bristol-Myers Squibb (Inst); Celldex (Inst); Merck (Inst)
 
Patrick Michael Dillon
Research Funding - Abbvie (Inst); Nektar (Inst); Newlink Genetics (Inst); Novartis (Inst); Pfizer (Inst)
 
Andrew J. Park
Research Funding - GlaxoSmithKline (Inst); MedImmune (Inst)
 
Paul Schwarzenberger
No Relationships to Disclose
 
Toni Ricciardi
Employment - Cascade Medical Enterprises
Stock and Other Ownership Interests - Becton Dickinson; Cascade Medical Enterprises
Consulting or Advisory Role - Cascade Medical Enterprises
 
Mary J. Macri
Employment - Eisai
Stock and Other Ownership Interests - Pfizer
 
Aileen Ryan
Stock and Other Ownership Interests - Amgen; Immunogen; Teva
 
Ralph Rudolph Venhaus
Stock and Other Ownership Interests - Dynavax Technologies; Soligenix
 
Jedd D. Wolchok
Stock and Other Ownership Interests - Potenza Therapeutics; Vesuvius Pharmaceuticals
Honoraria - Regeneron
Consulting or Advisory Role - Advaxis; Amgen; AstraZeneca; Beigene; Bristol-Myers Squibb; Chugai Pharma; FSC Pediatrics; Genentech; Jounce Therapeutics; Lilly; MedImmune; Merck; Polaris; Polynoma; Potenza Therapeutics; Sellas Life Sciences; Tizona Therapeutics, Inc.; ZIOPHARM Oncology
Research Funding - Bristol-Myers Squibb (Inst)
Patents, Royalties, Other Intellectual Property - I am a co-inventor on a patent for use of oncolytic Newcastle Disease virus.; I am a co-inventor on an issued patent for DNA vaccines for treatment of cancer in companion animals.
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Chugai Pharma; Janssen; Kadmon; Regeneron; Roche